We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Adocia Announces Failure of Phase 3 Trial

News   Aug 26, 2016

 
Adocia Announces Failure of Phase 3 Trial
 
 
Advertisement
 

RELATED ARTICLES

Pilot Study Suggests That Ivermectin Can Help To Treat Mild COVID-19

News

Results from a small pilot study indicate that the early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19.

READ MORE

Naltrexone–Bupropion Drug Combination May Help To Treat Methamphetamine Addiction

News

Combining the injectable drug naltrexone and a commonly prescribed antidepressant called bupropion was shown to produce positive results in 13.6 percent of 403 patients treated, significantly higher than the 2.5 percent response in placebo groups, in a study published in The New England Journal of Medicine.

READ MORE

Up to 20% of Glioblastomas Could Be Fueled by Overactive Mitochondria

News

A new study has found that up to 20% of glioblastomas – an aggressive type of brain cancer – are fueled by overactive mitochondria. The study also suggests that the mitochondrial subtype and may be treatable with existing drugs or investigational therapeutics currently in clinical development.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE